Probabilistic Markov Model to Assess the Cost-Effectiveness of Bronchodilator Therapy in COPD Patients in Different Countries
- 1 January 2005
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 8 (1), 32-46
- https://doi.org/10.1111/j.1524-4733.2005.03086.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Resource use and risk factors in high-cost exacerbations of COPDRespiratory Medicine, 2004
- Costs of Chronic Bronchitis and COPDaChest, 2003
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002
- The costs of exacerbations in chronic obstructive pulmonary disease (COPD)Respiratory Medicine, 2002
- Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.European Respiratory Journal, 2002
- The Impact of Aging and Smoking on the Future Burden of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Toward a Consensus Definition for COPD ExacerbationsChest, 2000
- The Prevalence of COPDChest, 2000
- Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Acute Exacerbation of COPDChest, 2000